ProKidney GAAP EPS of -$0.14 beats by $0.01, revenue of $0.23M beats by $0.03M

* ProKidney press release [https://seekingalpha.com/pr/20517549-prokidney-reports-first-quarter-2026-financial-results-and-business-highlights] (PROK [https://seekingalpha.com/symbol/PROK]): Q1 GAAP EPS of -$0.14 beats by $0.01.
* Revenue of $0.23M (flat Y/Y) beats by $0.03M.
* Cash, cash equivalents and marketable securities as of March 31, 2026, totaled $224.9 million, compared to $270.0 million as of December 31, 2025.
* "We expect that our existing cash, cash equivalents and marketable securities held at March 31, 2026, will enable us to fund our operating expenses and capital expenditure requirements into mid-2027."

MORE ON PROKIDNEY

* Seeking Alpha’s Quant Rating on ProKidney [https://seekingalpha.com/symbol/PROK/ratings/quant-ratings]
* Historical earnings data for ProKidney [https://seekingalpha.com/symbol/PROK/earnings]
* Financial information for ProKidney [https://seekingalpha.com/symbol/PROK/income-statement]